Biofoundries are a nucleating hub for industrial translation

Abstract Contemporary synthetic biology embraces the entire innovation pipeline; it is a transformative technology platform impacting new applications and improving existing industrial products and processes. However, challenges still emerge at the interface of upstream and downstream processes, integral to the value chain. It is now clear that biofoundries have a key role to play in addressing this; they provide unique and accessible infrastructure to drive the standardization necessary to deliver systematic design and engineering of biological systems and workflows. As for other biofoundries, the success of the London Biofoundry has been in part due to its expertise in establishing channels for industrial translation through its extensive strategic collaborations. It has also become cemented as a key component of various consortia and partnerships that serve the broader bioeconomy and industrial strategies. Adopting a networked approach enables links to be made between infrastructure, researchers, industrialists and policy makers to de-risk the economic challenges of scale-up, as well as contribute to the growing bioeconomy.

[1]  Paul Freemont,et al.  Design and Implementation of an Adaptive Pooling Workflow for SARS-CoV-2 Testing in an NHS Diagnostic Laboratory , 2021, SSRN Electronic Journal.

[2]  M. Ryadnov,et al.  Peptide Nanoparticles for Gene Packaging and Intracellular Delivery. , 2021, Methods in molecular biology.

[3]  Jacob Beal,et al.  Time to Get Serious about Measurement in Synthetic Biology. , 2018, Trends in biotechnology.

[4]  Y. Chisti.  Growing the bioeconomy , 2010 .

[5]  Manuel Porcar,et al.  The long journey towards standards for engineering biosystems , 2020, EMBO reports.

[6]  R. Kitney,et al.  Developing synthetic biology for industrial biotechnology applications , 2020, Biochemical Society transactions.

[7]  Jacob Beal,et al.  Synthetic biology open language (SBOL) version 3.0.0 , 2020, J. Integr. Bioinform..

[8]  Douglas C. Friedman,et al.  Building a global alliance of biofoundries , 2019, Nature Communications.

[9]  Hector Garcia Martin,et al.  A machine learning Automated Recommendation Tool for synthetic biology , 2019, Nature Communications.

[10]  Neil Swainston,et al.  Rapid prototyping of microbial production strains for the biomanufacture of potential materials monomers , 2020, Metabolic engineering.

[11]  Paul S. Freemont,et al.  Synthetic biology industry: data-driven design is creating new opportunities in biotechnology , 2019, Emerging topics in life sciences.

[12]  Tong Si,et al.  Accelerating strain engineering in biofuel research via build and test automation of synthetic biology. , 2021, Current opinion in biotechnology.

[13]  M. Ryadnov,et al.  Imaging and 3D Reconstruction of De Novo Peptide Capsids. , 2021, Methods in molecular biology.

[14]  Paul S Freemont,et al.  A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics , 2020, Nature Communications.

[15]  Jacob Beal,et al.  A standard-enabled workflow for synthetic biology. , 2017, Biochemical Society transactions.